5.1.1.2 Alkylating agent 5.1.2 Targeted Therapy
5.1.2.1 Proteasome inhibitor
5.2 By Drug Type
5.2.1 Corticosteroids 5.2.1.1 Dexamethasone ( Decadron ) 5.2.1.2 Prednisone ( Deltasone / Orasone )
5.2.2 Immunomodulatory agents 5.2.2.1 Thalidomide ( Thalomid ) 5.2.2.2 Lenalidomide ( Revlimid ) 5.2.2.3 Arsenic trioxide ( Trisenox ) 5.2.2.4 Plerixafor ( Mozobil )
6 . Geographical Analysis
6.1 North America 6.1.1 Introduction 6.1.2 United States 6.1.3 Canada
6.2 Europe 6.2.1 Introduction 6.2.2 U . K 6.2.3 Spain 6.2.4 Germany 6.2.5 Italy 6.2.6 France
6.3 Asia-Pacific 6.3.1 Introduction 6.3.2 China 6.3.3 India 6.3.4 Japan 6.3.5 South Korea 6.3.6 Australia
6.4 Latin America 6.4.1 Introduction